Entries by admin

QR Pharma Reports Results from SBIR Grant by NIA/NIH to Study Posiphen® and Metabolites in Various Models

Berwyn, PA, October 13, 2011 QR Pharma, Inc., a clinical-stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of cognitive impairment and Alzheimer’s disease (AD), along with the Medical University of South Carolina (MUSC) report on the results obtained from the Small Business Innovation Research (SBIR) phase I grant study […]

QR Pharma to Present Poster at International Conference on Alzheimer’s Disease

Berwyn, PA, July 12, 2011 QR Pharma, Inc., a developer of novel compounds for the treatment of cognitive impairment, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative disorders, announced today that Dr. Maria Maccecchini, chief executive officer, will present a poster entitled “Mechanism of Action of Posiphen®: from Model to Human” at the Alzheimer’s Association International […]

QR Pharma to Present at 10th Annual World Pharma Congress on Parkinson’s Disease

Berwyn, PA, June 2, 2011 QR Pharma, Inc., a developer of novel compounds to treat Alzheimer’s disease and neurodegenerative disorders, announced today that Dr. Maria Maccecchini, chief executive officer, will speak at Cambridge Healthtech Institute’s 10th Annual World Pharma Congress Drug Discovery Summit – Targeting Parkinson’s Disease, in Philadelphia, PA. Dr. Maccecchini will present “Inhibition […]

QR Pharma to Present at 2nd Annual World Congress of NeuroTalk

Berwyn, PA, May 18, 2011 QR Pharma, Inc. a developer of novel compounds to treat Alzheimer’s disease and neurodegenerative disorders, announced today that Dr. Maria Maccecchini, chief executive officer, will speak at the BIT 2nd Annual World Congress of NeuroTalk-2011 in Dalian, China. Dr. Maccecchini will co-chair a session on Anti-Neurodegenerative Drug Discovery and will […]

QR Pharma to Present at BIO-Windhover Conference /Pharmaceutical Strategic Outlook 2011

Radnor, PA, March 31, 2011 QR Pharma, Inca developer of novel compounds to treat Alzheimer’s disease and neurodegenerative disorders, announced today that Dr. Maria Maccecchini, chief executive officer, is scheduled to speak at the BIO-Windhover/Pharmaceutical Strategic Outlook conference in New York City, NY. Dr. Maccecchini will provide a corporate overview and update on the company’s […]